KVUE | tickerfilter.com

Fundamental analysis

63%

Profitability 70%

Dept financing 41%

Liquidity 31%

Performance 71%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.54%

1 Month

-1.65%

3 Months

-2.75%

6 Months

14.71%

1 Year

-24.54%

2 Year

-10.64%

Key data

Stock price

$17.31

P/E Ratio

22.15

DAY RANGE

$17.21 - $17.42

EPS

$0.71

52 WEEK RANGE

$14.02 - $25.17

52 WEEK CHANGE

-$23.91

MARKET CAP

32.560 B

YIELD

4.85%

SHARES OUTSTANDING

1.917 B

DIVIDEND

$0.2075

EX-DIVIDEND DATE

02-11-2026

NEXT EARNINGS DATE

08-05-2025

BETA

-0.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

$15,646,512

AVERAGE 30 VOLUME

$18,011,948

Company detail

CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: NYSE
Industry: Consumer Goods/Perfumes, Cosmetics And Other Toilet Preparations
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

KVUE - Kenvue Inc.